A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)
Shenzhen Majory Biotechnology Co., Ltd.
Shenzhen Majory Biotechnology Co., Ltd.
Nanjing Leads Biolabs Co.,Ltd
MediLink Therapeutics (Suzhou) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fujian Cancer Hospital
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Thomas Jefferson University
Henan Cancer Hospital
FeRx